|
|
 |
|
Viewing report
|
|
|
|
Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, 2nd Edition
John Wiley and Sons Ltd, Sep 2006, Pages: 402
Preface for the Second Edition.
Preface for the First Edition.
1 Introduction.
1.1 Neuroactive Substances.
1.1.1 Neurotransmitters.
1.1.2 Neuromodulators.
1.2 Receptors and Transporters.
1.2.1 Ionotropic Receptors.
1.2.2 Metabotropic Receptors.
1.2.3 Receptor Regulation.
1.2.4 Transporters.
1.3 Distribution and Localization of Neurotransmitters and Neuromodulators.
1.4 The Blood–Brain Barrier.
1.5 Volume Transmission and Wiring Transmission.
2 Methods.
2.1 Bio- and Radioisotope Assays.
2.2 Microdialysis and Electrochemical Detection.
2.2.1 Microdialysis.
2.2.2 Electrochemical Detection.
2.3 Chromatography.
2.3.1 Affinity Chromatography.
2.3.2 High Performance Liquid Chromatography.
2.3.3 Proteomics: Multidimensional Protein Identification Technology.
2.4 Autoradiography.
2.5 Immunohistochemical Methods.
2.6 In situ Hybridization.
2.7 Staining and Neuroanatomical Tract Tracing.
2.8 Electrophysiology.
2.8.1 In vivo Recording.
2.8.2 In vitro Recording.
2.9 Behavioral Testing.
2.9.1 Classic Conditioning.
2.9.2 Operant Conditioning.
2.9.3 Further Behavioral Tests.
3 Neurotransmitters.
3.1 Acetylcholine.
3.1.1 General Aspects and History.
3.1.2 Localization Within the Central Nervous System.
3.1.3 Biosynthesis and Degradation.
3.1.4 Receptors and Signal Transduction.
3.1.5 Biological Effects.
3.1.6 Neurological Disorders and Neurogenerative Diseases.
3.2 Dopamine.
3.2.1 General Aspects and History.
3.2.2 Differentiation and Localization of the Dopaminergic System.
3.2.3 Biosynthesis and Degradation.
3.2.4 Release, Re-uptake and Degradation.
3.2.5 Receptors and Signal Transduction.
3.2.6 Biological Effects.
3.2.7 Neurological Disorders and Neurodegenerative Diseases.
3.3 _-Amino Butyric Acid.
3.3.1 General Aspects and History.
3.3.2 Localization Within the Central Nervous System.
3.3.3 Biosynthesis and Degradation.
3.3.4 GABA Transporters.
3.3.5 Receptors and Signal Transduction.
3.3.6 Biological Effects.
3.3.7 Neurological Disorders and Neurogenerative Diseases.
3.4 Glutamate and Aspartate.
3.4.1 General Aspects and History.
3.4.2 Localization Within the Central Nervous System.
3.4.3 Biosynthesis and Degradation.
3.4.4 Transporters.
3.4.5 Receptors and Signal Transduction.
3.4.6 Biological Effects.
3.4.7 Neurological Disorders and Neurodegenerative Diseases.
3.5 Glycine.
3.5.1 General Aspects and History.
3.5.2 Localization Within the Central Nervous System.
3.5.3 Biosynthesis and Degradation.
3.5.4 Receptors and Signal Transduction.
3.5.5 Biological Effects.
3.5.6 Neurological Disorders and Neurodegenerative Diseases.
3.6 Histamine.
3.6.1 General Aspects and History.
3.6.2 Localization Within the Central Nervous System.
3.6.3 Biosynthesis and Degradation.
3.6.4 Receptors and Signal Transduction.
3.6.5 Biological Effects.
3.6.6 Neurological Disorders and Neurodegenerative Diseases.
3.7 Norepinephrine.
3.7.1 General Aspects and History.
3.7.2 Localization Within the Central Nervous System.
3.7.3 Biosynthesis and Degradation.
3.7.4 Receptors and Signal Transduction.
3.7.5 Biological Effects.
3.7.6 Neurological Disorders and Neurodegenerative Diseases.
3.8 Serotonin (5-Hydroxytryptamine).
3.8.1 General Aspects and History.
3.8.2 Localization Within the Central Nervous System.
3.8.3 Biosynthesis and Degradation.
3.8.4 Receptors and Signal Transduction.
3.8.5 Biological Effects.
3.8.6 Neurological Disorders and Neurodegenerative Diseases.
4 Neuromodulators.
4.1 Adrenocorticotropic Hormone.
4.1.1 General Aspects and History.
4.1.2 Localization Within the Central Nervous System.
4.1.3 Biosynthesis and Degradation.
4.1.4 Receptors and Signal Transduction.
4.1.5 Biological Effects.
4.1.6 Neurological Disorders and Neurodegenerative Diseases.
4.2 Anandamide (Endocannabinoids).
4.2.1 General Aspects and History.
4.2.2 Localization Within the Central Nervous System.
4.2.3 Biosynthesis and Degradation.
4.2.4 Receptors and Signal Transduction.
4.2.5 Biological Effects.
4.2.6 Neurological Disorders and Neurodegenerative Diseases.
4.3 Angiotensin.
4.3.1 General Aspects and History.
4.3.2 Localization Within the Central Nervous System.
4.3.3 Biosynthesis and Degradation.
4.3.4 Receptors and Signal Transduction.
4.3.5 Biological Effects.
4.3.6 Neurological Disorders and Neurodegenerative Diseases.
4.4 Atrial Natriuretic Factor.
4.4.1 General Aspects and History.
4.4.2 Localization Within the Central Nervous System.
4.4.3 Biosynthesis and Degradation.
4.4.4 Receptors and Signal Transduction.
4.4.5 Biological Effects.
4.4.6 Neurological Disorders and Neurodegenerative Diseases.
4.5 Bombesin and Related Neuropeptides.
4.5.1 General Aspects and History.
4.5.2 Localization Within the Central Nervous System.
4.5.3 Biosynthesis and Degradation.
4.5.4 Receptors and Signal Transduction.
4.5.5 Biological Effects.
4.6 Calcitonin and Calcitonin Gene-related Protein.
4.6.1 General Aspects and History.
4.6.2 Localization Within the Central Nervous System.
4.6.3 Biosynthesis and Degradation.
4.6.4 Receptors and Signal Transduction.
4.6.5 Biological Effects.
4.6.6 Neurological Disorders and Neurodegenerative Diseases.
4.7 Cholecystokinin.
4.7.1 General Aspects and History.
4.7.2 Localization Within the Central Nervous System.
4.7.3 Biosynthesis and Degradation.
4.7.4 Receptors and Signal Transduction.
4.7.5 Biological Effects.
4.7.6 Neurological Disorders and Neurodegenerative Diseases.
4.8 Corticotropin-releasing Factor.
4.8.1 General Aspects and History.
4.8.2 Localization Within the Central Nervous System.
4.8.3 Biosynthesis and Degradation.
4.8.4 Receptors and Signal Transduction.
4.8.5 Biological Effects.
4.8.6 Neurological Disorders and Neurodegenerative Diseases.
4.9 Dynorphin.
4.9.1 General Aspects and History.
4.9.2 Localization Within the Central Nervous System.
4.9.3 Biosynthesis and Degradation.
4.9.4 Receptors and Signal Transduction.
4.9.5 Biological Effects.
4.9.6 Neurological Disorders and Neurodegenerative Diseases.
4.10 Eicosanoids and Arachidonic Acid.
4.10.1 General and History Aspects.
4.10.2 Biosynthesis and Degradation.
4.10.3 Receptors and Signal Transduction.
4.10.4 Biological Effects.
4.10.5 Neurological Disorders and Neurodegenerative Diseases.
4.11 Endorphin.
4.11.1 General Aspects and History.
4.11.2 Localization Within the Central Nervous System.
4.11.3 Biosynthesis and Degradation.
4.11.4 Biological Effects.
4.11.5 Neurological Disorders and Neurodegenerative Diseases.
4.12 Enkephalin.
4.12.1 General Aspects and History.
4.12.2 Localization Within the Central Nervous System.
4.12.3 Biosynthesis and Degradation.
4.12.4 Receptors and Signal Transduction.
4.12.5 Biological Effects.
4.12.6 Neurological Disorders and Neurodegenerative Diseases.
4.13 Fibroblast Growth Factors.
4.13.1 General Aspects and History.
4.13.2 Localization Within the Central Nervous System.
4.13.3 Biosynthesis and Degradation.
4.13.4 Receptors and Signal Transduction.
4.13.5 Biological Effects.
4.13.6 Neurological Disorders and Neurodegenerative Diseases.
4.14 Galanin.
4.14.1 General Aspects and History.
4.14.2 Localization Within the Central Nervous System.
4.14.3 Biosynthesis and Degradation.
4.14.4 Receptors and Signal Transduction.
4.14.5 Biological Effects.
4.14.6 Neurological Disorders and Neurodegenerative Diseases.
4.15 Ghrelin.
4.15.1 General Aspects and History.
4.15.2 Localization Within the Central Nervous System.
4.15.3 Biosynthesis and Degradation.
4.15.4 Receptors and Signal Transduction.
4.15.5 Biological Effects.
4.15.6 Neurological Disorders and Neurodegenerative Diseases.
4.16 Gonadotropin-releasing Hormone.
4.16.1 General Aspects and History.
4.16.2 Localization Within the Central Nervous System.
4.16.3 Biosynthesis and Degradation.
4.16.4 Receptors and Signal Transduction.
4.16.5 Biological Effects.
4.16.6 Neurological Disorders and Neurodegenerative Diseases.
4.17 Growth Hormone-releasing Hormone.
4.17.1 General Aspects and History.
4.17.2 Localization Within the Central Nervous System.
4.17.3 Biosynthesis and Degradation.
4.17.4 Receptors and Signal Transduction.
4.17.5 Biological Effects.
4.17.6 Neurological Disorders and Neurodegenerative Diseases.
4.18 Hypocretin (Orexin).
4.18.1 General Aspects and History.
4.18.2 Localization Within the Central Nervous System.
4.18.3 Biosynthesis and Degradation.
4.18.4 Receptors and Signal Transduction.
4.18.5 Biological Effects.
4.18.6 Neurological Disorders and Neurodegenerative Diseases.
4.19 Interleukin.
4.19.1 General Aspects.
4.19.2 Localization Within the Central Nervous System.
4.19.3 Biosynthesis and Degradation.
4.19.4 Receptors and Signal Transduction.
4.19.5 Biological Effects.
4.19.6 Neurological Disorders and Neurodegenerative Diseases.
4.20 Melanin-concentrating Hormone.
4.20.1 General Aspects and History.
4.20.2 Localization Within the Central Nervous System.
4.20.3 Biosynthesis and Degradation.
4.20.4 Receptors and Signal Transduction.
4.20.5 Biological Effects.
4.20.6 Neurological Disorders and Neurodegenerative Diseases.
4.21 Melanocyte-stimulating Hormone.
4.21.1 General Aspects.
4.21.2 Localization Within the Central Nervous System.
4.21.3 Biosynthesis and Degradation.
4.21.4 Receptors and Signal Transduction.
4.21.5 Biological Effects.
4.21.6 Neurological Disorders and Neurodegenerative Diseases.
4.22 Neuropeptide Y.
4.22.1 General Aspects and History.
4.22.2 Localization Within the Central Nervous System.
4.22.3 Biosynthesis and Degradation.
4.22.4 Receptors and Signal Transduction.
4.22.5 Biological Effects.
4.22.6 Neurological Disorders and Neurodegenerative Diseases.
4.23 Neurotensin.
4.23.1 General Aspects and History.
4.23.2 Localization Within the Central Nervous System.
4.23.3 Biosynthesis and Degradation.
4.23.4 Receptors and Signal Transduction.
4.23.5 Biological Effects.
4.23.6 Neurological Disorders and Neurodegenerative Diseases.
4.24 Neurotrophins.
4.24.1 General Aspects and History.
4.24.2 Localization Within the Central Nervous System.
4.24.3 Biosynthesis and Degradation.
4.24.4 Receptors and Signal Transduction.
4.24.5 Biological Effects.
4.24.6 Neurological Disorders and Neurodegenerative Diseases.
4.25 Nitric Oxide and Carbon Monoxide.
4.25.1 General Aspects and History.
4.25.2 Localization Within the Central Nervous System.
4.25.3 Biosynthesis and Degradation.
4.25.4 Receptors and Signal Transduction.
4.25.5 Biological Functions.
4.25.6 Neurological Disorders and Neurodegenerative Diseases.
4.26 Nociceptin (Orphanin FQ).
4.26.1 General Aspects and History.
4.26.2 Localization Within the Central Nervous System.
4.26.3 Biosynthesis and Degradation.
4.26.4 Receptors and Signal Transduction.
4.26.5 Biological Effects.
4.26.6 Neurological Disorders and Neurodegenerative Diseases.
4.27 Pituitary Adenylate Cyclase-activating Polypeptide.
4.27.1 General Aspects and History.
4.27.2 Localization Within the Central Nervous System.
4.27.3 Biosynthesis and Degradation.
4.27.4 Receptors and Signal Transduction.
4.27.5 Biological Effects.
4.27.6 Neurological Disorders and Neurodegenerative Diseases.
4.28 Proopiomelanocortin.
4.28.1 General Aspects and History.
4.28.2 Localization Within the Central Nervous System.
4.28.3 Biosynthesis and Degradation.
4.28.4 Receptors and Signal Transduction.
4.28.5 Biological Effects.
4.29 Purines.
4.29.1 General Aspects.
4.29.2 Biosynthesis and Degradation.
4.29.3 Receptors and Signal Transduction.
4.29.4 Biological Effects.
4.29.5 Neurological Disorders and Neurodegenerative Diseases.
4.30 Somatostatin.
4.30.1 General Aspects and History.
4.30.2 Localization Within the Central Nervous System.
4.30.3 Biosynthesis and Degradation.
4.30.4 Receptors and Signal Transduction.
4.30.5 Biological Effects.
4.30.6 Neurological Disorders and Neurodegenerative Diseases.
4.31 Substance P and Tachykinins.
4.31.1 General Aspects and History.
4.31.2 Localization Within the Central Nervous System.
4.31.3 Biosynthesis and Degradation.
4.31.4 Receptors and Signal Transduction.
4.31.5 Biological Effects.
4.31.6 Neurological Disorders and Neurodegenerative Diseases.
4.32 Thyrotropin-releasing Hormone.
4.32.1 General Aspects and History.
4.32.2 Localization Within the Central Nervous System.
4.32.3 Biosynthesis and Degradation.
4.32.4 Receptors and Signal Transduction.
4.32.5 Biological Effects.
4.32.6 Neurological Disorders and Neurodegenerative Diseases.
4.33 The Tyr-MIF-1 Family.
4.34 Vasoactive Intestinal Polypeptide.
4.34.1 General Aspects and History.
4.34.2 Localization Within the Central Nervous System.
4.34.3 Biosynthesis and Degradation.
4.34.4 Receptors and Signal Transduction.
4.34.5 Biological Effects.
4.34.6 Neurological Disorders and Neurodegenerative Diseases.
4.35 Vasopressin and Oxytocin.
4.35.1 General Aspects and History.
4.35.2 Localization Within the Central Nervous System.
4.35.3 Biosynthesis and Degradation.
4.35.4 Receptors and Signal Transduction.
4.35.5 Biological Effects.
4.35.6 Neurological Disorders and Neurodegenerative Diseases.
4.36 Deorphanized Neuropeptides.
4.36.1 Apelin.
4.36.2 Kisspeptin/Metastin.
4.36.3 Opiod-modulating Peptides (NPFF and NPAF).
A Appendix.
A1 Amino Acids.
A2 Nucleotides.
A3 Abbreviations for Neurotransmitters and Neuromodulators.
A4 Miscellaneous Abbreviations (Enzymes and Transporters).
Subject Index.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Biochemistry of Signal Transduction and Regulation, 4th Edition
Drug Discovery for Nervous System Diseases
G Protein-coupled Receptors: Molecular Pharmacology
Personalized Medicine - Scientific and Commercial Aspects
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report
Nuclear Receptors in Drug Metabolism
Nomadic Callers: Localization in Emergency Situations
Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets
Proteomics of the Nervous System
Partneringdesk Deals and alliances in central nervous system diseases
Central Nervous System Psychotic Disorders
|
|
|
|
